mrna/CORONA
Robinhood MRNA is a tokenized representation of Moderna, Inc. (MRNA) common stock, issued on Robinhood Chain, Robinhood's own blockchain built to bring tokenized real-world assets on-chain. Each token is designed to track the price of the underlying MRNA share, giving holders on-chain price exposure to Moderna, Inc.'s stock. The token is freely transferable and composable across the Robinhood Chain ecosystem. It's part of Robinhood's broader initiative to expand access to tokenized U.S. equities via blockchain technology, alongside a wider lineup of tokenized stock tokens launching on the same network.
Score | 48 |
|---|---|
24h Vol | $0 |
Liquidity | $20.8K |
Holders | 1.5K |
Audits | |
Age | 14 days |
FDV | $202.3K |
Market Cap | $769K |
mrna to CORONA Converter
Score | 48 |
|---|---|
24h Vol | $0 |
Liquidity | $20.8K |
Holders | 1.5K |
Audits | |
Age | 14 days |
FDV | $202.3K |
Market Cap | $769K |
About Moderna, Inc. • Robinhood Token (mrna)
Robinhood MRNA is a tokenized representation of Moderna, Inc. (MRNA) common stock, issued on Robinhood Chain, Robinhood's own blockchain built to bring tokenized real-world assets on-chain. Each token is designed to track the price of the underlying MRNA share, giving holders on-chain price exposure to Moderna, Inc.'s stock. The token is freely transferable and composable across the Robinhood Chain ecosystem. It's part of Robinhood's broader initiative to expand access to tokenized U.S. equities via blockchain technology, alongside a wider lineup of tokenized stock tokens launching on the same network.
Other Pools Trading Moderna, Inc. • Robinhood Token (mrna)
mrna/CORONA Price Stats
The current price of mrna (mrna/CORONA) on Bankr (Robinhood) is $163.01, the price is up 0% in the last 24 hours. Its 24-hour trading volume is reported to be at $0.00 with a total of 0 transactions. mrna/CORONA contract address is 0x0e121deb48fba4f28e8d011b7a5ffc54c4ba925ea4fa8ac0587ff15f2b5f5710, with a Fully Diluted Valuation (FDV) of $768.99K and a liquidity pool of $20,798.58.
